Publikationen zur Studie "Klinische Surveillance der HIV-Erkrankung (ClinSurv)"

Die klinische Surveillance der HIV-Erkrankung (ClinSurv-HIV) ist eine offene, multizentrische, deutschlandweite, prospektive Langzeitbeobachtungsstudie, deren Ziel es ist, Einflussfaktoren auf den klinischen Verlauf der HIV-Erkrankung zu erfassen (weitere Informationen unter www.rki.de/clinsurv-hiv).

2024

Pantke A, Kollan C, Gunsenheimer-Bartmeyer B, Jensen B-EO, Stephan C, Degen O, et al. AIDS-defining events among people living with HIV who have been under continuous antiretroviral therapy for more than one year, a German cohort study 1999–2018. Infection. 2024. https://doi.org/10.1007/s15010-024-02188-y

nach oben

2023

Pantke, A., Kollan, C., Gunsenheimer-Bartmeyer, B., Jensen, B. O., Stephan, C., Degen, O., Schürmann, D., Kurth, T., Bremer, V., Koppe, U., & HIV-1 Seroconverter Cohort and the ClinSurv HIV Cohort (2023). AIDS in the era of antiretroviral therapy: Changes in incidence rates and predictors of AIDS among people living with HIV under clinical care in Germany, a cohort study 1999-2018. HIV medicine, 24(7), 794–806. https://doi.org/10.1111/hiv.13482

nach oben

2021

Koppe, U., Poertner, K., Kollan, C., Gunsenheimer-Bartmeyer, B., an der Heiden, M., Schmidt, D., ... & Esser, S. (2021). Long-term development of CD4 values in German HIV patients under successful antiretroviral therapy-analysis from the ClinSurv cohort 1999-2018. In INFECTION (Vol. 49, No. SUPPL 1, pp. S8-S9). https://doi.org/10.1007/s15010-021-01588-8

Koppe, U., Poertner, K., Kollan, C., Gunsenheimer-Bartmeyer, B., an der Heiden, M., Der, A., ... & Esser, S. (2021). Reaching CD4 values>= 650 cells/mu l in German HIV patients under successful long-term antiretroviral therapy-analysis from the ClinSurv cohort 1999-2018. In HIV MEDICINE (Vol. 22, SUPPL 3, pp. 100-101). https://doi.org/10.1111/hiv.13183

Poertner, K., Kollan, C., an der Heiden, M., Gunsenheimer-Bartmeyer, B., Schmidt, D., Esser, S., ... & Koppe, U. (2021). CD4/CD8-ratio normalisation by first-line ART-class combination in ClinSurv, a large multicentre HIV-cohort study from Germany 1999-2018. In INFECTION (Vol. 49, No. SUPPL 1, pp. S9-S10). https://doi.org/10.1007/s15010-021-01588-8

Schmidt, D., Kollan, C., Stoll, M., Hamouda, O., Bremer, V., Kurth, T., Bartmeyer, B., HIV-1 Seroconverter cohort, & ClinSurv HIV cohort (2021). Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999-2018). BMC public health, 21(1), 200. https://doi.org/10.1186/s12889-020-10088-7

Caby, F., Guiguet, M., Weiss, L., Winston, A., Miro, J. M., Konopnicki, D., Le Moing, V., Bonnet, F., Reiss, P., Mussini, C., Poizot-Martin, I., Taylor, N., Skoutelis, A., Meyer, L., Goujard, C., Bartmeyer, B., Boesecke, C., Antinori, A., Quiros-Roldan, E., Wittkop, L., … (CD4/CD8 ratio and cancer risk) project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord (2021). CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 73(1), 50–59. https://doi.org/10.1093/cid/ciaa1137

nach oben

2020

Stecher, M., Schommers, P., Kollan, C., Stoll, M., Kuhlendahl, F., Stellbrink, H.J., Wasmuth, J.C., Stephan, C., Hamacher, L., Lehmann, C., Boesecke, C., Bogner, J., Esser, S., Fritzsche, C., Haberl, A., Schürmann, D., Degen, O., Horst, H. A., Hoffmann, C., Jensen, B., Schwarze-Zander, C., Platten, M., Fätkenheuer, G., Schmidt, D. , Gunsenheimer-Bartmeyer, B., Vehreschild, J.J., & ClinSurv Study Group (2020). Correction to: Treatment modifcation after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005-2017. Infection, 49(6), 1365–1366. https://doi.org/10.1007/s15010-021-01655-0

nach oben

2019

Koppe, U., Hanke, K., Fiebig, U., Schmidt, D., Meixenberger, K., Pantke, A., Gunsenheimer-Bartmeyer, B., Kollan, C., Kühne, A., Marcus, U., Bannert, N., Bremer, V. (2019): HIV Studien und HIV-Projekte am Robert Koch-Institut. Epid. Bull. 2019 (49): 527-539. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2019/49/Art_01.html

Stecher, M., Schommers, P., Schmidt, D., Kollan, C., Gunsenheimer-Bartmeyer, B., Lehmann, C., Platten, M., Fätkenheuer, G., Vehreschild, J. J., & ClinSurv Study Group (2019). Correction to: Antiretroviral treatment indications and adherence to the German-Austrian treatment initiation guidelines in the German ClinSurv HIV Cohort between 1999 and 2016. Infection, 47(2), 257. https://doi.org/10.1007/s15010-019-01281-x

nach oben

2018

Schmidt, D., Kollan, C., Stoll, M., Stellbrink, H.-J., Plettenberg, A., Fätkenheuer, G., Bergmann, F., Bogner, J.-R., van Luzen, J., Rockstroh, J., Esser, S., Jensen, B.-E.-O., Horst, H.-A., Fritzsche, C., Kühne, A., an der Heiden, M., Hamouda, O., Bartmeyer, B., & ClinSurv Study Group (2018): Compendium of good practices in the health sector response to HIV in the WHO European Region (2018) with From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany. World Health Organization, ISBN 978 92 890 5335 8.

Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord (for RKI: Bartmeyer B, Hamouda O) (2018): Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? HIV Medicine (2018) 19, 42-48. https://doi.org/10.1111/hiv.12536

IeDEA and COHERE Cohort Collaborations (2018). Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 66(6), 893–903. https://doi.org/10.1093/cid/cix915

nach oben